Author

Behzad Baradaran

Immunology Research Center, Tabriz University of Medical Sciences - Cited by 21,421 - Immunology - cancer - antibody

Biography

Behzad Baradaran is currently working as a Professor in the Department of Immunology. His research interests includes immunology, vaccination. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his  Administrative responsibilities. Behzad Baradaran has authored of many research articles/books related to Immunology, vaccination.
Title
Cited by
Year
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis
N Shomali, B Baradaran, AD Sorkhabi, A Sarkesh, MS Kahrizi, F Tosan, ...Gene 844, 14829, 2022202
6
2022
Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies
S Abbasi, MA Totmaj, M Abbasi, S Hajazimian, P Goleij, J Behroozi, ...Cancer Medicine, 20220
3
2023
Rheumatoid arthritis and non-coding RNAs; how to trigger inflammation
R Tofigh, M Hosseinpourfeizi, B Baradaran, S Teimourian, ...Life Sciences, 12167, 20220
3
2023
CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer
S Ghahremani Dehbokri, N Alizadeh, A Isazadeh, A Baghbanzadeh, ...Current Molecular Medicine 3 (6), 51-56, 030
2
2023
Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin
S Noorolyai, E Baghbani, S Mahboob, F Zargari, A Sorkhabi, P Sameti, ...Pathology-Research and Practice 40, 154194, 0
2
2022
Hyaluronic acid-functionalized gold nanoparticles as a cancer diagnostic probe for targeted bioimaging applications
M Hejazi, S Arshadi, M Amini, B Baradaran, P Shahbazi-Derakhshi, ...Microchemical Journal 93, 08953, 2023202
1
2023
A novel water-soluble thiosemicarbazone Schiff base ligand and its complexes as potential anticancer agents and cellular fluorescence imaging
S Feizpour, SA Hosseini-Yazdi, E Safarzadeh, B Baradaran, M Dusek, ...JBIC Journal of Biological Inorganic Chemistry, -6, 2023202
1
2023
Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?
F Ghorbaninezhad, H Alemohammad, B Najafzadeh, J Masoumi, ...Cancer Letters, 2668, 2023202
1
2023
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis
M Afrashteh Nour, F Ghorbaninezhad, Z Asadzadeh, A Baghbanzadeh, ...Therapeutic Advances in Chronic Disease 4, 204062232353572, 2023202
1
2023
Acetyl carnitine modified liposomes elevate cisplatin uptake in macrophage and cancer cells
F Zahednezhad, P Zakeri-Milani, JS Mojarrad, M Sarfraz, M Mahmoudian, ...Journal of Drug Delivery Science and Technology 8, 0498, 2023202
1
2023
Silencing tumor-intrinsic HHLA2 potentiates the anti-tumoral effect of paclitaxel on MG63 cells: Another side of immune checkpoint
NK Ahangar, M Khalaj-Kondori, N Alizadeh, A Mokhtarzadeh, ...Gene 855, 47086, 2023202
1
2023
The effect of miR-4800 restoration on proliferation and migration of human breast cancer cells in vitro
M Khordadmehr, R Matin, B Baradaran, E Baghbani, F Jigari-Asl, ...Advanced Pharmaceutical Bulletin 3 (2), 378, 2023202
1
2023
Anticancer properties of curcumin-treated Lactobacillus plantarum against the HT-29 colorectal adenocarcinoma cells
F Gholipour, M Amini, B Baradaran, A Mokhtarzadeh, M EskandaniScientific Reports 3 (), 2860, 2023202
1
2023
Immune checkpoints and their promising prospect in cholangiocarcinoma treatment in combination with other therapeutic approaches
F Vatankhah, N Salimi, A Khalaji, B BaradaranInternational Immunopharmacology 4, 09526, 2023202
1
2023